Clinical Trials Logo

Clinical Trial Summary

Bleedings in the upper digestive tract are common. Usually, laboratory and clinical parameters are considered to establish a suspicion for a bleeding in the digestive tract and to estimate urgency of the situation. If these parameters suggest the presence of a bleeding in the digestive tract, endoscopies are often performed to further investigate a patient's status. The above-mentioned laboratory and clinical parameters are sometimes not specific enough to reliably identify a bleeding in the upper digestive tract. The HemoPill acute is capsule device, that has a built in sensor that detects blood in the upper digestive tract. This information is valuable for the medical personnel and complements the information that is obtained from other laboratory or clinical tests


Clinical Trial Description

The purpose of the study was to access safety and accuracy of Hemopill and its receiver. Patients scheduled for endoscopy on the basis of suspected UGIB are generally eligible for inclusion into the trial. After patient screening, information and obtaining informed consent, a patient is enrolled into the trial. Shortly before the scheduled endoscopy is performed, the patient ingests a HemoPill acute. Endoscopy is performed as scheduled. Blood within the GI lumen is identified if present and pictures are taken. Pathologies, if found, are treated as per clinical standard. The HemoPill acute measurement regarding presence or absence of blood in the GI lumen is compared to observations made during endoscopy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05415124
Study type Interventional
Source NYU Langone Health
Contact Sofia Yuen
Phone 646-501-7931
Email sofia.yuen@nyulangone.org
Status Recruiting
Phase N/A
Start date June 17, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Terminated NCT01448382 - Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study Phase 1
Recruiting NCT06167837 - Metoclopramide for Gastric Visualization in Active Upper GI Bleeding Phase 4
Recruiting NCT05746377 - Metoclopramide in Upper Gastrointestinal Bleed Phase 4
Recruiting NCT05582174 - PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers Phase 4
Not yet recruiting NCT06254352 - Clinical Risk Scores in Prediction Outcome of Acute UGIT Bleeding in Non Cirrhotic Patients
Recruiting NCT05474937 - Inhalation of Sevoflurane Versus Intravenous Midazolam,Ketamine,Propofol For Pediatrics Undergoing Upper GI Endoscopy N/A
Recruiting NCT05457062 - Analysis the Vocs in Upper GI Bleeding Patients
Recruiting NCT05876741 - Validation of Prognostic Accuracy of ABC ( Age, Blood Urea Nitrogen , Co-morbidities ) and Horibe Pre-endoscopy Scoring Systems in Patients With Upper Gastrointestinal Bleeding in Sohag University Hospital .
Recruiting NCT05763745 - Bedside Ultrasonic Assessment for Gastric Content in Patients With Upper GI Bleeding Undergoing Endoscopy: a Pilot Study N/A
Completed NCT03176407 - Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING] N/A